CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy
Histopathology (2023) - Comments
doi: 10.1111/his.14910  issn: 0309-0167  issn: 1365-2559  pubmed: 36994939 

Mario L. Marques‐Piubelli, Do Hwan Kim, L. Jeffrey Medeiros, Wei Lu, Khaja Khan, Lorena Isabel Gomez‐Bolanos, Saxon Rodriguez, Edwin R. Parra, Chi Young Ok, Akanksha Aradhya, Luisa M Solis, Yago L. Nieto, Raphael Steiner, Sairah Ahmed, Francisco Vega